Recently, diagnostic tests for Parkinson’s disease have focused on elevated levels of the α-synuclein protein in cerebrospinal fluid (CSF) or mitochondrial DNA in the blood, both of which can vary ...

Aditxt subsidiary Pearsanta has secured approval from WCG Clinical’s Institutional Review Board (IRB) to begin a clinical ...

A medical breakthrough could result in the first treatment for rare but serious diseases in which genetic defects disrupt ...

Researchers at the University of Gothenburg have identified a small molecule, PZL-A, that restores function in the defective ...